SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EGR3
|
ENSG00000179388.8 | early growth response 3 |
EGR2
|
ENSG00000122877.9 | early growth response 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EGR3 | hg19_v2_chr8_-_22549856_22549927 | 0.62 | 3.4e-03 | Click! |
EGR2 | hg19_v2_chr10_-_64576105_64576133 | -0.08 | 7.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_50192833 | 2.51 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr6_+_43739697 | 2.32 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
chr15_+_39873268 | 2.30 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr4_-_36246060 | 1.96 |
ENST00000303965.4
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr12_-_57634475 | 1.89 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr18_+_33877654 | 1.73 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr4_-_90758227 | 1.71 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr1_-_9189229 | 1.66 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr1_-_182361327 | 1.46 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr1_+_43148625 | 1.44 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chr11_-_64612041 | 1.41 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr22_+_33197683 | 1.40 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr15_+_41136216 | 1.28 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr19_-_51472031 | 1.27 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51472222 | 1.24 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
chr5_+_131593364 | 1.20 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr1_+_68150744 | 1.19 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
chr5_+_137801160 | 1.19 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr9_+_34989638 | 1.18 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr1_+_43148059 | 1.15 |
ENST00000321358.7
ENST00000332220.6 |
YBX1
|
Y box binding protein 1 |
chr11_-_65640198 | 1.12 |
ENST00000528176.1
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
chr7_+_90225796 | 1.11 |
ENST00000380050.3
|
CDK14
|
cyclin-dependent kinase 14 |
chr1_-_6321035 | 1.10 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr10_-_27444143 | 1.09 |
ENST00000477432.1
|
YME1L1
|
YME1-like 1 ATPase |
chr11_-_125366089 | 1.08 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr15_+_74833518 | 1.02 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr19_-_39264072 | 1.00 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
chr11_+_129939779 | 1.00 |
ENST00000533195.1
ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
chr11_+_129939811 | 0.99 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
chr2_-_27718052 | 0.97 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr9_-_35115836 | 0.95 |
ENST00000378566.1
ENST00000378554.2 ENST00000322813.5 |
FAM214B
|
family with sequence similarity 214, member B |
chr6_-_112194484 | 0.94 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr1_+_6508100 | 0.94 |
ENST00000461727.1
|
ESPN
|
espin |
chr3_+_50192499 | 0.94 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr3_+_50192457 | 0.94 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr1_+_26606608 | 0.93 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr3_+_50192537 | 0.92 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr15_+_98503922 | 0.91 |
ENST00000268042.6
|
ARRDC4
|
arrestin domain containing 4 |
chr19_-_49371711 | 0.91 |
ENST00000355496.5
ENST00000263265.6 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
chr12_-_54785074 | 0.91 |
ENST00000338010.5
ENST00000550774.1 |
ZNF385A
|
zinc finger protein 385A |
chr2_+_148778570 | 0.89 |
ENST00000407073.1
|
MBD5
|
methyl-CpG binding domain protein 5 |
chr12_-_54785054 | 0.88 |
ENST00000352268.6
ENST00000549962.1 |
ZNF385A
|
zinc finger protein 385A |
chr6_+_37787704 | 0.87 |
ENST00000474522.1
|
ZFAND3
|
zinc finger, AN1-type domain 3 |
chr8_-_127570603 | 0.86 |
ENST00000304916.3
|
FAM84B
|
family with sequence similarity 84, member B |
chr15_+_41136369 | 0.86 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr19_+_11071685 | 0.86 |
ENST00000541122.2
ENST00000589677.1 ENST00000444061.3 |
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
chr4_+_76649753 | 0.85 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
chr1_+_6484829 | 0.84 |
ENST00000377828.1
|
ESPN
|
espin |
chr6_+_35310391 | 0.84 |
ENST00000337400.2
ENST00000311565.4 ENST00000540939.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
chr20_+_35201993 | 0.84 |
ENST00000373872.4
|
TGIF2
|
TGFB-induced factor homeobox 2 |
chr19_+_11071652 | 0.83 |
ENST00000344626.4
ENST00000429416.3 |
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
chr22_-_30722866 | 0.83 |
ENST00000403477.3
|
TBC1D10A
|
TBC1 domain family, member 10A |
chr3_+_37903432 | 0.83 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr19_-_2051223 | 0.83 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr8_+_94929273 | 0.82 |
ENST00000518573.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr3_-_18486354 | 0.81 |
ENST00000493952.2
ENST00000440737.1 |
SATB1
|
SATB homeobox 1 |
chr6_+_35310312 | 0.81 |
ENST00000448077.2
ENST00000360694.3 ENST00000418635.2 ENST00000444397.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
chr5_+_63461642 | 0.81 |
ENST00000296615.6
ENST00000381081.2 ENST00000389100.4 |
RNF180
|
ring finger protein 180 |
chr8_+_94929168 | 0.81 |
ENST00000518107.1
ENST00000396200.3 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr2_-_98612350 | 0.80 |
ENST00000186436.5
|
TMEM131
|
transmembrane protein 131 |
chr8_+_94929077 | 0.80 |
ENST00000297598.4
ENST00000520614.1 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr6_-_42110342 | 0.80 |
ENST00000356542.5
|
C6orf132
|
chromosome 6 open reading frame 132 |
chr19_-_49565254 | 0.78 |
ENST00000593537.1
|
NTF4
|
neurotrophin 4 |
chr8_-_57123815 | 0.77 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr14_+_94640633 | 0.76 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr4_-_90758118 | 0.75 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr11_-_65640071 | 0.74 |
ENST00000526624.1
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
chr9_-_101017900 | 0.74 |
ENST00000375066.5
|
TBC1D2
|
TBC1 domain family, member 2 |
chr19_-_2050852 | 0.74 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr19_+_11071546 | 0.73 |
ENST00000358026.2
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
chr8_-_75233563 | 0.73 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
chr8_+_94929110 | 0.72 |
ENST00000520728.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr1_-_23694794 | 0.72 |
ENST00000374608.3
|
ZNF436
|
zinc finger protein 436 |
chr16_+_3070356 | 0.71 |
ENST00000341627.5
ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr11_+_8704748 | 0.69 |
ENST00000526562.1
ENST00000525981.1 |
RPL27A
|
ribosomal protein L27a |
chr13_-_45915221 | 0.69 |
ENST00000309246.5
ENST00000379060.4 ENST00000379055.1 ENST00000527226.1 ENST00000379056.1 |
TPT1
|
tumor protein, translationally-controlled 1 |
chr13_-_77460525 | 0.68 |
ENST00000377474.2
ENST00000317765.2 |
KCTD12
|
potassium channel tetramerization domain containing 12 |
chr19_+_39279838 | 0.66 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr14_+_94640671 | 0.66 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr4_-_119274121 | 0.66 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
chr10_+_112631699 | 0.66 |
ENST00000444997.1
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
chr22_-_30722912 | 0.66 |
ENST00000215790.7
|
TBC1D10A
|
TBC1 domain family, member 10A |
chr22_+_37956453 | 0.65 |
ENST00000249014.4
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1 |
chr8_-_139926236 | 0.65 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
chr17_-_47439437 | 0.64 |
ENST00000430262.2
|
ZNF652
|
zinc finger protein 652 |
chr3_+_101546827 | 0.64 |
ENST00000461724.1
ENST00000483180.1 ENST00000394054.2 |
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
chr19_-_51568324 | 0.64 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr15_+_41136586 | 0.63 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr17_+_79008940 | 0.63 |
ENST00000392411.3
ENST00000575989.1 ENST00000321280.7 ENST00000428708.2 ENST00000575712.1 ENST00000575245.1 ENST00000435091.3 ENST00000321300.6 |
BAIAP2
|
BAI1-associated protein 2 |
chr1_-_9189144 | 0.63 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
chr19_-_45908292 | 0.62 |
ENST00000360957.5
ENST00000592134.1 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
chr4_-_82393052 | 0.62 |
ENST00000335927.7
ENST00000504863.1 ENST00000264400.2 |
RASGEF1B
|
RasGEF domain family, member 1B |
chr18_-_28622699 | 0.61 |
ENST00000360428.4
|
DSC3
|
desmocollin 3 |
chr19_-_51529849 | 0.61 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr11_-_125366018 | 0.61 |
ENST00000527534.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr18_-_28622774 | 0.61 |
ENST00000434452.1
|
DSC3
|
desmocollin 3 |
chr11_-_125365435 | 0.60 |
ENST00000524435.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr8_+_57124245 | 0.60 |
ENST00000521831.1
ENST00000355315.3 ENST00000303759.3 ENST00000517636.1 ENST00000517933.1 ENST00000518801.1 ENST00000523975.1 ENST00000396723.5 ENST00000523061.1 ENST00000521524.1 |
CHCHD7
|
coiled-coil-helix-coiled-coil-helix domain containing 7 |
chr3_-_171177852 | 0.60 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
chrX_+_153686614 | 0.60 |
ENST00000369682.3
|
PLXNA3
|
plexin A3 |
chr5_-_140998616 | 0.59 |
ENST00000389054.3
ENST00000398562.2 ENST00000389057.5 ENST00000398566.3 ENST00000398557.4 ENST00000253811.6 |
DIAPH1
|
diaphanous-related formin 1 |
chr15_+_40733387 | 0.59 |
ENST00000416165.1
|
BAHD1
|
bromo adjacent homology domain containing 1 |
chr16_+_2564254 | 0.59 |
ENST00000565223.1
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
chrX_-_132549506 | 0.58 |
ENST00000370828.3
|
GPC4
|
glypican 4 |
chr19_-_37341673 | 0.58 |
ENST00000586323.1
|
ZNF790
|
zinc finger protein 790 |
chr3_+_184279566 | 0.58 |
ENST00000330394.2
|
EPHB3
|
EPH receptor B3 |
chrX_-_48814810 | 0.58 |
ENST00000376488.3
ENST00000396743.3 ENST00000156084.4 |
OTUD5
|
OTU domain containing 5 |
chr19_-_49568311 | 0.57 |
ENST00000595857.1
ENST00000451356.2 |
NTF4
|
neurotrophin 4 |
chr6_+_12012536 | 0.57 |
ENST00000379388.2
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
chr11_+_66886717 | 0.57 |
ENST00000398645.2
|
KDM2A
|
lysine (K)-specific demethylase 2A |
chr22_+_38035623 | 0.57 |
ENST00000336738.5
ENST00000442465.2 |
SH3BP1
|
SH3-domain binding protein 1 |
chr5_+_31193847 | 0.57 |
ENST00000514738.1
ENST00000265071.2 |
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney) |
chr2_+_220306745 | 0.56 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
chr19_-_51523412 | 0.56 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
chr6_+_37137939 | 0.56 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr19_-_46916805 | 0.56 |
ENST00000307522.3
|
CCDC8
|
coiled-coil domain containing 8 |
chr22_+_38035459 | 0.56 |
ENST00000357436.4
|
SH3BP1
|
SH3-domain binding protein 1 |
chr15_-_41408339 | 0.55 |
ENST00000401393.3
|
INO80
|
INO80 complex subunit |
chr16_+_50776021 | 0.55 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr17_+_7255208 | 0.55 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
chr13_-_52027134 | 0.55 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
chr3_-_126194707 | 0.54 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
chr11_+_64009072 | 0.53 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
chr1_-_23670752 | 0.53 |
ENST00000302271.6
ENST00000426846.2 ENST00000427764.2 ENST00000606561.1 ENST00000374616.3 |
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
chr14_-_21737610 | 0.52 |
ENST00000320084.7
ENST00000449098.1 ENST00000336053.6 |
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
chr5_-_140998481 | 0.52 |
ENST00000518047.1
|
DIAPH1
|
diaphanous-related formin 1 |
chr11_-_94964354 | 0.52 |
ENST00000536441.1
|
SESN3
|
sestrin 3 |
chrX_+_21959108 | 0.52 |
ENST00000457085.1
|
SMS
|
spermine synthase |
chr6_+_138188378 | 0.52 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr1_-_29508321 | 0.52 |
ENST00000546138.1
|
SRSF4
|
serine/arginine-rich splicing factor 4 |
chr15_-_43882353 | 0.52 |
ENST00000453080.1
ENST00000360301.4 ENST00000360135.4 ENST00000417085.1 ENST00000431962.1 ENST00000334933.4 ENST00000381879.4 ENST00000420765.1 |
PPIP5K1
|
diphosphoinositol pentakisphosphate kinase 1 |
chr5_-_115177247 | 0.52 |
ENST00000500945.2
|
ATG12
|
autophagy related 12 |
chr6_+_2765595 | 0.51 |
ENST00000380773.4
ENST00000380771.4 |
WRNIP1
|
Werner helicase interacting protein 1 |
chr11_+_126081662 | 0.51 |
ENST00000528985.1
ENST00000529731.1 ENST00000360194.4 ENST00000530043.1 |
FAM118B
|
family with sequence similarity 118, member B |
chr7_+_70229899 | 0.51 |
ENST00000443672.1
|
AUTS2
|
autism susceptibility candidate 2 |
chr12_+_70760056 | 0.51 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr3_-_124774802 | 0.51 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
chr19_-_51523275 | 0.50 |
ENST00000309958.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr1_-_33647267 | 0.50 |
ENST00000291416.5
|
TRIM62
|
tripartite motif containing 62 |
chr19_+_48673949 | 0.50 |
ENST00000328759.7
|
C19orf68
|
chromosome 19 open reading frame 68 |
chr19_+_45844018 | 0.50 |
ENST00000585434.1
|
KLC3
|
kinesin light chain 3 |
chr1_+_36771946 | 0.50 |
ENST00000373139.2
ENST00000453908.2 ENST00000426732.2 |
SH3D21
|
SH3 domain containing 21 |
chr12_-_93323013 | 0.50 |
ENST00000322349.8
|
EEA1
|
early endosome antigen 1 |
chrX_+_117480036 | 0.49 |
ENST00000371822.5
ENST00000254029.3 ENST00000371825.3 |
WDR44
|
WD repeat domain 44 |
chr14_-_21737551 | 0.49 |
ENST00000554891.1
ENST00000555883.1 ENST00000553753.1 ENST00000555914.1 ENST00000557336.1 ENST00000555215.1 ENST00000556628.1 ENST00000555137.1 ENST00000556226.1 ENST00000555309.1 ENST00000556142.1 ENST00000554969.1 ENST00000554455.1 ENST00000556513.1 ENST00000557201.1 ENST00000420743.2 ENST00000557768.1 ENST00000553300.1 ENST00000554383.1 ENST00000554539.1 |
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
chr6_+_138188551 | 0.49 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr15_+_84116106 | 0.48 |
ENST00000535412.1
ENST00000324537.5 |
SH3GL3
|
SH3-domain GRB2-like 3 |
chr6_-_33266687 | 0.48 |
ENST00000444031.2
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2 |
chr21_+_37692481 | 0.48 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
chr1_-_23670813 | 0.48 |
ENST00000374612.1
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
chr20_-_61569296 | 0.47 |
ENST00000370371.4
|
DIDO1
|
death inducer-obliterator 1 |
chr16_+_29817841 | 0.47 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr18_+_12288288 | 0.47 |
ENST00000586226.1
|
RP11-64C12.8
|
RP11-64C12.8 |
chr3_+_133292851 | 0.47 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
chr19_-_16682987 | 0.47 |
ENST00000431408.1
ENST00000436553.2 ENST00000595753.1 |
SLC35E1
|
solute carrier family 35, member E1 |
chr17_-_1619568 | 0.47 |
ENST00000571595.1
|
MIR22HG
|
MIR22 host gene (non-protein coding) |
chr19_+_45843994 | 0.47 |
ENST00000391946.2
|
KLC3
|
kinesin light chain 3 |
chr6_+_12012170 | 0.47 |
ENST00000487103.1
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
chr4_-_153274078 | 0.47 |
ENST00000263981.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr11_+_64685026 | 0.46 |
ENST00000526559.1
|
PPP2R5B
|
protein phosphatase 2, regulatory subunit B', beta |
chr19_-_54984354 | 0.46 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr11_+_8704298 | 0.46 |
ENST00000531978.1
ENST00000524496.1 ENST00000532359.1 ENST00000530022.1 |
RPL27A
|
ribosomal protein L27a |
chr1_-_40042073 | 0.46 |
ENST00000372858.3
|
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
chr13_-_52026730 | 0.46 |
ENST00000420668.2
|
INTS6
|
integrator complex subunit 6 |
chr22_+_37956479 | 0.46 |
ENST00000430687.1
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1 |
chr15_+_41136263 | 0.45 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr8_+_144821557 | 0.45 |
ENST00000534398.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
chr15_-_42783303 | 0.45 |
ENST00000565380.1
ENST00000564754.1 |
ZNF106
|
zinc finger protein 106 |
chr1_+_155051305 | 0.44 |
ENST00000368408.3
|
EFNA3
|
ephrin-A3 |
chr6_-_10413112 | 0.43 |
ENST00000465858.1
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr14_+_77648167 | 0.43 |
ENST00000554346.1
ENST00000298351.4 |
TMEM63C
|
transmembrane protein 63C |
chr8_+_26149274 | 0.43 |
ENST00000522535.1
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr17_+_8924837 | 0.43 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
chr11_-_94964210 | 0.43 |
ENST00000416495.2
ENST00000393234.1 |
SESN3
|
sestrin 3 |
chr19_+_37096194 | 0.42 |
ENST00000460670.1
ENST00000292928.2 ENST00000439428.1 |
ZNF382
|
zinc finger protein 382 |
chr4_+_76649797 | 0.42 |
ENST00000538159.1
ENST00000514213.2 |
USO1
|
USO1 vesicle transport factor |
chr12_-_31479107 | 0.42 |
ENST00000542983.1
|
FAM60A
|
family with sequence similarity 60, member A |
chr21_-_40720974 | 0.42 |
ENST00000380748.1
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
chr19_-_14228541 | 0.42 |
ENST00000590853.1
ENST00000308677.4 |
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha |
chr16_+_50775971 | 0.42 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr2_-_9143786 | 0.42 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
chr6_+_44095347 | 0.42 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
chr7_+_100797726 | 0.42 |
ENST00000429457.1
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
chr7_+_20370300 | 0.41 |
ENST00000537992.1
|
ITGB8
|
integrin, beta 8 |
chr3_-_69249863 | 0.41 |
ENST00000478263.1
ENST00000462512.1 |
FRMD4B
|
FERM domain containing 4B |
chr1_-_23670817 | 0.41 |
ENST00000478691.1
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
chr11_+_114310164 | 0.41 |
ENST00000544196.1
ENST00000539754.1 ENST00000539275.1 |
REXO2
|
RNA exonuclease 2 |
chr16_+_69139467 | 0.41 |
ENST00000569188.1
|
HAS3
|
hyaluronan synthase 3 |
chr14_+_59655369 | 0.41 |
ENST00000360909.3
ENST00000351081.1 ENST00000556135.1 |
DAAM1
|
dishevelled associated activator of morphogenesis 1 |
chr1_-_38471156 | 0.40 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
chr5_-_176924562 | 0.40 |
ENST00000359895.2
ENST00000355572.2 ENST00000355841.2 ENST00000393551.1 ENST00000505074.1 ENST00000356618.4 ENST00000393546.4 |
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr1_-_29508499 | 0.40 |
ENST00000373795.4
|
SRSF4
|
serine/arginine-rich splicing factor 4 |
chr5_-_178054105 | 0.40 |
ENST00000316308.4
|
CLK4
|
CDC-like kinase 4 |
chr7_+_150782945 | 0.40 |
ENST00000463381.1
|
AGAP3
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
chr20_+_34894247 | 0.40 |
ENST00000373913.3
|
DLGAP4
|
discs, large (Drosophila) homolog-associated protein 4 |
chr12_-_6715808 | 0.39 |
ENST00000545584.1
|
CHD4
|
chromodomain helicase DNA binding protein 4 |
chr5_-_178054014 | 0.39 |
ENST00000520957.1
|
CLK4
|
CDC-like kinase 4 |
chr20_-_17662878 | 0.39 |
ENST00000377813.1
ENST00000377807.2 ENST00000360807.4 ENST00000398782.2 |
RRBP1
|
ribosome binding protein 1 |
chr19_+_45409011 | 0.39 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr5_-_133706695 | 0.39 |
ENST00000521755.1
ENST00000523054.1 ENST00000435240.2 ENST00000609654.1 ENST00000536186.1 ENST00000609383.1 |
CDKL3
|
cyclin-dependent kinase-like 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.8 | 2.3 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 2.5 | GO:0051585 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.5 | 2.4 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.5 | 1.4 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.4 | 1.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.4 | 1.2 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
0.4 | 5.3 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.4 | 1.1 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
0.4 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.4 | 1.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 1.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 1.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.3 | 2.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.7 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.2 | 0.6 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.2 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 3.1 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 2.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 1.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.6 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.9 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 2.7 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.6 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.1 | 0.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.5 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 2.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 1.9 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 3.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.3 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.1 | 0.5 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.1 | 0.3 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
0.1 | 0.3 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.2 | GO:1903299 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.5 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 1.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 2.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 1.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.3 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.1 | 0.3 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.1 | 0.3 | GO:0001300 | chronological cell aging(GO:0001300) |
0.1 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.1 | 0.5 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.2 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.1 | 0.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.6 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.1 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.1 | 0.7 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.1 | 0.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 1.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.3 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.2 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 1.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.6 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 1.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 1.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.3 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.0 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 1.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.3 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.1 | GO:0071106 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.0 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.2 | GO:0032796 | uropod organization(GO:0032796) |
0.0 | 0.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 1.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 | 0.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.0 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 1.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.0 | 0.4 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.0 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.0 | 0.1 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.0 | 0.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 1.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.3 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 0.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.0 | 0.1 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
0.0 | 0.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 0.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.2 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.0 | 0.1 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.0 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:0072708 | response to sorbitol(GO:0072708) |
0.0 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.0 | 0.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.0 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) |
0.0 | 0.1 | GO:0048320 | axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
0.0 | 0.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.0 | 0.3 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.0 | 0.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.0 | 0.1 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.0 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.2 | GO:0090032 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.3 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.2 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.0 | 0.1 | GO:0090669 | snoRNA 3'-end processing(GO:0031126) telomerase RNA stabilization(GO:0090669) |
0.0 | 1.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.6 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.1 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 2.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.8 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 1.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.2 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0030217 | T cell differentiation(GO:0030217) |
0.0 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.3 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.0 | 0.5 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0070458 | establishment of blood-nerve barrier(GO:0008065) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.5 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.3 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.0 | 0.0 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.0 | 1.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 0.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.2 | 1.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 2.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0036019 | endolysosome(GO:0036019) endolysosome membrane(GO:0036020) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.4 | GO:0000806 | Y chromosome(GO:0000806) |
0.1 | 1.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 1.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 4.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 2.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 1.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0001740 | X chromosome(GO:0000805) Barr body(GO:0001740) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.8 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 1.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 1.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 2.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 3.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 2.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 1.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.7 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 1.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 3.3 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.5 | 3.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 2.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 1.5 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 1.0 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.2 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.2 | 0.6 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.2 | 1.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 3.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 1.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 0.7 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 2.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 5.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.8 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.8 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.2 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 1.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) histone demethylase activity(GO:0032452) |
0.1 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.0 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.1 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.0 | 0.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.2 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.0 | 0.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.0 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.0 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 1.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 4.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 0.0 | GO:1900750 | glutathione binding(GO:0043295) prostaglandin-E synthase activity(GO:0050220) oligopeptide binding(GO:1900750) |
0.0 | 2.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 4.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 1.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 1.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 5.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.0 | 0.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 2.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 6.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.0 | 1.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.2 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 7.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 2.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 2.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 7.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 4.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 6.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 2.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |